April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Identification of Novel Endoplasmic Reticulum Ubiquitin E3 Ligase Involved in Regulation of Angiogenesis
Author Affiliations & Notes
  • Armin Maghsoudlou
    Boston University, Boston, MA
  • Rosana D Meyer
    Boston University, Boston, MA
  • Edward Hartsough
    Boston University, Boston, MA
  • Nader Rahimi
    Boston University, Boston, MA
  • Footnotes
    Commercial Relationships Armin Maghsoudlou, None; Rosana Meyer, None; Edward Hartsough, None; Nader Rahimi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1326. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Armin Maghsoudlou, Rosana D Meyer, Edward Hartsough, Nader Rahimi; Identification of Novel Endoplasmic Reticulum Ubiquitin E3 Ligase Involved in Regulation of Angiogenesis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1326.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Ocular angiogenesis is a hallmark of many debilitating eye diseases including wet age related macular degeneration and diabetic retinopathy. Vascular endothelial growth factor-A (VEGF-A), a principal mediator of neovascularization/angiogenesis, is a major cause of the disease's progression. Because of its central role in angiogenesis, the most successful CNV treatments have also relied on the blocking of the VEGF-A pathway. Activation of VEGFR-2 by VEGF family ligands mediates most of the known VEGF cellular responses leading to angiogenesis. The overall aim of this project is to understand the molecular mechanisms by which post - translational modifications on the VEGFR-2 control ocular angiogenesis, and how disruption of these post - translational modifications in pathological conditions contribute to aberrant angiogenesis.

Methods: We used various cell culture based assays including transfection and western blot analysis to establish the interaction of RNF-121 with VEGFR-2. Immunofluorescence microscopy was used to establish cellular localization of RNF-121. Western blotting and immunohistochemistry assays were used to analyze expression of RNF-121 in endothelial cells.

Results: We have identified Ring Finger-121 (RNF-121) protein as a novel endoplasmic reticulum (ER) ubiquitin E3 ligase expressed in endothelial cells. RNF-121 directly associates with newly synthesized VEGFR-2 protein. RNF-121 mediates ubiquitination of VEGFR-2, a post-translational modification that targets VEGFR-2 to proteasomal degradation. RNF-121-dependnet degradation of VEGFR-2 reduces the presence of functional VEGFR-2 at the surface of endothelial cells and inhibits angiogenesis.

Conclusions: RNF-121 is a novel ubiquitin E3 ligase of VEGFR-2. RNF-121 plays an important role in angiogenesis by limiting the availability of VEGFR-2 at the surface endothelial cells and significantly reduces the angiogenic activity of VEGF-A.

Keywords: 748 vascular endothelial growth factor • 657 protein modifications-post translational • 688 retina  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.